Shares of Novavax Inc. /zigman2/quotes/202614340/composite NVAX -2.88% inched 0.95% higher to $89.33 Friday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP -0.52% rising 1.58% to 14,098.01 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.45% falling 0.06% to 35,089.74. The stock's rise snapped a two-day losing streak. Novavax Inc. closed $242.35 below its 52-week high ($331.68), which the company reached on February 9th.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Replimune Group Inc. /zigman2/quotes/203971249/composite REPL +2.15% rose 0.05% to $18.26, VBI Vaccines Inc. /zigman2/quotes/201705917/composite VBIV -2.10% rose 2.65% to $1.55, and AnaptysBio Inc. /zigman2/quotes/205822596/composite ANAB +0.72% rose 4.25% to $31.37. Trading volume (3.3 M) remained 3.4 million below its 50-day average volume of 6.7 M.